BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Bayer CropScience AG Ends Myconate Deal with Plant Health Care


12/18/2008 6:47:11 AM

Dec 18 (Reuters) - Plant Health Care Plc said on Thursday that Bayer CropScience AG (BAYG.DE: Quote, Profile, Research, Stock Buzz) terminated an agreement to develop seed treatments based on Plant Health Care's Myconate technology, sending shares of the British natural plant products company down 24 percent.

Plant Health Care said it would receive no further payments from Bayer CropScience in 2009, but added it was confident that its full-year revenue and profit would be in line with market estimates.

Under the agreement, signed in January 2007, Plant Health Care was to receive an undisclosed up-front payment, two milestone payments over a two-year period, depending on progress, and supply payments.

Myconate, derived from natural sources, is a soil amendment that helps crops like corn and soybeans produce better yields, especially under adverse environmental conditions.

Separately, Plant Health Care said it was in talks with a number of parties including major agrichemical companies on possible collaboration to further develop and commercialise Myconate, and it expected to conclude another significant development deal in 2009.

In September, Bayer CropScience announced a long-term licence agreement to use Plant Health Care's harpin genes in brassica oilseeds, a key ingredient in vegetable oils.

Plant Health Care said on Tuesday it had agreed with U.S. biotech company Monsanto Co (MON.N: Quote, Profile, Research, Stock Buzz) on the commercialisation of a harpin-based seed treatment for row crops and vegetables.

At 0844 GMT, Plant Health Care shares were down 24 percent at 168 pence. (Reporting by Kumar Alagappan in Bangalore; Editing by Mike Miller)


Read at BioSpace.com

Related News

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->